Cargando…

Participatory Workshops are Not Enough to Prevent Policy Implementation Failures: An Example of a Policy Development Process Concerning the Drug Interferon-beta for Multiple Sclerosis

A possible explanation for policy implementation failure is that the views of the policy’s target groups are insufficiently taken into account during policy development. It has been argued that involving these groups in an interactive process of policy development could improve this. We analysed a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Moret-Hartman, Margriet, Reuzel, Rob, Grin, John, van der Wilt, Gert Jan
Formato: Texto
Lenguaje:English
Publicado: Springer US 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362137/
https://www.ncbi.nlm.nih.gov/pubmed/17929170
http://dx.doi.org/10.1007/s10728-007-0069-1
_version_ 1782153386048618496
author Moret-Hartman, Margriet
Reuzel, Rob
Grin, John
van der Wilt, Gert Jan
author_facet Moret-Hartman, Margriet
Reuzel, Rob
Grin, John
van der Wilt, Gert Jan
author_sort Moret-Hartman, Margriet
collection PubMed
description A possible explanation for policy implementation failure is that the views of the policy’s target groups are insufficiently taken into account during policy development. It has been argued that involving these groups in an interactive process of policy development could improve this. We analysed a project in which several target populations participated in workshops aimed to optimise the utilisation of an expensive novel drug (interferon beta) for patients with Multiple Sclerosis. All participants seemed to agree on the appropriateness of establishing a central registry of Multiple Sclerosis patients and developing guidelines. Nevertheless, these policy measures were not implemented. Possible explanations include (1) the subject no longer had high priority when the costs appeared lower than expected, (2) the organisers had paid insufficient attention to the perceived problems of parties involved, and (3) changes within the socio-political context. The workshops in which representatives of the policy’s target populations participated did not provide enough interactivity to prevent policy implementation failure.
format Text
id pubmed-2362137
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-23621372008-05-01 Participatory Workshops are Not Enough to Prevent Policy Implementation Failures: An Example of a Policy Development Process Concerning the Drug Interferon-beta for Multiple Sclerosis Moret-Hartman, Margriet Reuzel, Rob Grin, John van der Wilt, Gert Jan Health Care Anal Original Article A possible explanation for policy implementation failure is that the views of the policy’s target groups are insufficiently taken into account during policy development. It has been argued that involving these groups in an interactive process of policy development could improve this. We analysed a project in which several target populations participated in workshops aimed to optimise the utilisation of an expensive novel drug (interferon beta) for patients with Multiple Sclerosis. All participants seemed to agree on the appropriateness of establishing a central registry of Multiple Sclerosis patients and developing guidelines. Nevertheless, these policy measures were not implemented. Possible explanations include (1) the subject no longer had high priority when the costs appeared lower than expected, (2) the organisers had paid insufficient attention to the perceived problems of parties involved, and (3) changes within the socio-political context. The workshops in which representatives of the policy’s target populations participated did not provide enough interactivity to prevent policy implementation failure. Springer US 2007-10-11 2008-06 /pmc/articles/PMC2362137/ /pubmed/17929170 http://dx.doi.org/10.1007/s10728-007-0069-1 Text en © Springer Science+Business Media, LLC 2007
spellingShingle Original Article
Moret-Hartman, Margriet
Reuzel, Rob
Grin, John
van der Wilt, Gert Jan
Participatory Workshops are Not Enough to Prevent Policy Implementation Failures: An Example of a Policy Development Process Concerning the Drug Interferon-beta for Multiple Sclerosis
title Participatory Workshops are Not Enough to Prevent Policy Implementation Failures: An Example of a Policy Development Process Concerning the Drug Interferon-beta for Multiple Sclerosis
title_full Participatory Workshops are Not Enough to Prevent Policy Implementation Failures: An Example of a Policy Development Process Concerning the Drug Interferon-beta for Multiple Sclerosis
title_fullStr Participatory Workshops are Not Enough to Prevent Policy Implementation Failures: An Example of a Policy Development Process Concerning the Drug Interferon-beta for Multiple Sclerosis
title_full_unstemmed Participatory Workshops are Not Enough to Prevent Policy Implementation Failures: An Example of a Policy Development Process Concerning the Drug Interferon-beta for Multiple Sclerosis
title_short Participatory Workshops are Not Enough to Prevent Policy Implementation Failures: An Example of a Policy Development Process Concerning the Drug Interferon-beta for Multiple Sclerosis
title_sort participatory workshops are not enough to prevent policy implementation failures: an example of a policy development process concerning the drug interferon-beta for multiple sclerosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362137/
https://www.ncbi.nlm.nih.gov/pubmed/17929170
http://dx.doi.org/10.1007/s10728-007-0069-1
work_keys_str_mv AT morethartmanmargriet participatoryworkshopsarenotenoughtopreventpolicyimplementationfailuresanexampleofapolicydevelopmentprocessconcerningthedruginterferonbetaformultiplesclerosis
AT reuzelrob participatoryworkshopsarenotenoughtopreventpolicyimplementationfailuresanexampleofapolicydevelopmentprocessconcerningthedruginterferonbetaformultiplesclerosis
AT grinjohn participatoryworkshopsarenotenoughtopreventpolicyimplementationfailuresanexampleofapolicydevelopmentprocessconcerningthedruginterferonbetaformultiplesclerosis
AT vanderwiltgertjan participatoryworkshopsarenotenoughtopreventpolicyimplementationfailuresanexampleofapolicydevelopmentprocessconcerningthedruginterferonbetaformultiplesclerosis